Promises
2 promises
Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →Gujarat Fluorochemicals Limited — Q3 FY24
GFL reported Q3 FY24 consolidated revenue of INR 1,992 crore (up 5% QoQ) and EBITDA of INR 206 crore (up 26% QoQ), with EBITDA margin expanding 400 bps QoQ to 21%.
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
GFL reported Q3 FY24 consolidated revenue of INR 1,992 crore (up 5% QoQ) and EBITDA of INR 206 crore (up 26% QoQ), with EBITDA margin expanding 400 bps QoQ to 21%. The recovery was driven by bottoming of bulk chemicals and refrigerant segments, though fluoropolymers saw seasonal volume decline. Management sees green shoots and expects FY25 to approach FY23 levels, driven by fluoropolymer volume growth and higher-grade mix. Key risks include delayed destocking recovery and Chinese dumping in specialty chemicals. Guidance for FY25 EBITDA at par with FY23 (vs. earlier 'better than FY23') signals tempered optimism.
GFL ने Q3 FY24 में कुल आय 1,992 करोड़ रुपये (पिछली तिमाही से 5% ज़्यादा) और EBITDA 206 करोड़ रुपये (26% ज़्यादा) दर्ज किया। EBITDA मार्जिन 4% बढ़कर 21% हो गया। यह सुधार बल्क केमिकल्स और रेफ्रिजरेंट सेगमेंट में गिरावट रुकने से हुआ, हालांकि फ्लोरोपॉलीमर की बिक्री मौसमी कमी के कारण घटी। कंपनी को उम्मीद है कि FY25 में फ्लोरोपॉलीमर की बिक्री और बेहतर क्वालिटी के दम पर कारोबार FY23 के स्तर पर पहुंच जाएगा। मुख्य जोखिम हैं: स्टॉक खत्म होने में देरी और चीन से सस्ते केमिकल्स की डंपिंग। FY25 के लिए EBITDA का अनुमान FY23 के बराबर रखा गया है, जो पहले के 'FY23 से बेहतर' अनुमान से कम उत्साह दिखाता है।
Promises0 met · 2 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Delayed destocking recovery in fluoropolymers
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
EBITDA Margin QoQ Expansion
21%
+400 bps QoQ
EBITDA margin improved 400 bps sequentially to 21% in Q3 FY24.
Fluoropolymer Capacity Ramp-up Target
1,800-1,900 TPM
+700-800 TPM from 1,100 TPM
Target to increase fluoropolymer capacity from 1,100 to 1,800-1,900 tons per month over next few quarters.
CapEx for FY25 (ex-EV)
INR 500 crore
Reduced from earlier INR 1,500 crore plan
FY25 CapEx for existing business reduced to INR 500 crore, with EV CapEx separate.
Legacy Player Inventory Depletion Timeline
1-2 quarters
N/A
Management expects legacy player inventory to deplete in 1-2 quarters, aiding fluoropolymer demand.
What Changed vs Last Quarter
NEW
FY25 EBITDA at par with FY23
Management revised guidance: FY25 EBITDA will be at similar levels to FY23 (INR ~1,900 crore), not higher, with a possible quarter variance.
NEW
CapEx for existing business at INR 500 crore in FY25
CapEx for non-EV business in FY25 will be around INR 500 crore, staggered from earlier plans.
NEW
Fluoropolymer capacity ramp-up over next 4 quarters
New fluoropolymer capacity (1,800-1,900 TPM) will be utilized over the next four quarters as approvals and customer validations progress.
NEW
Battery chemical revenue from H2 FY25
Revenue from battery chemicals (PVDF) expected to start from second half of FY25, with meaningful contribution from FY26.
DROPPED
FY25 revenue and profit to surpass FY23 levels
Management expects FY25 to be better than FY23, implying recovery to peak levels.
DROPPED
30% EBITDA margin target for FY25
Management reaffirms 30% EBITDA margin as normal run-rate, expecting to achieve it in FY25.
DROPPED
H2 FY24 better than H1 FY24
Management expects gradual improvement in H2 due to destocking phasing out and legacy player exits.
DROPPED
Battery chemical sampling to start shortly
Integrated LiPF6 and electrolyte plants are in advanced commissioning; customer sampling imminent.
NEW RISK
Delayed destocking recovery in fluoropolymers
Legacy player inventory may take longer to deplete than expected, delaying volume recovery.
NEW RISK
Chinese dumping in specialty chemicals
Specialty chemical segment remains under pressure due to dumping from China, with no near-term improvement expected.
NEW RISK
EV business CapEx and dilution risk
Analyst raised concern about funding of EV CapEx and potential dilution; management deferred answer to separate EV call.
NEW RISK
FY25 EBITDA guidance revision
Management revised FY25 EBITDA guidance from 'better than FY23' to 'at par with FY23', indicating slower recovery.
RISK GONE
Chinese dumping in low-end PTFE
Continued price pressure from Chinese and Russian competitors in commodity PTFE grades may persist, impacting margins.
RISK GONE
Refrigerant volume recovery uncertain
US phase-out of R125 and circumvention issues have structurally impacted export volumes; recovery may be limited.
RISK GONE
Inventory destocking drag on margins
High-cost inventory led to gross margin compression; normalization may take another quarter.
RISK GONE
PFAS regulatory risk
Despite management's confidence, PFAS regulations in Europe and US could impact fluoropolymer demand if scope widens.
Fast read
Guidance and risk preview
Management revised guidance: FY25 EBITDA will be at similar levels to FY23 (INR ~1,900 crore), not higher, with a possible quarter variance.
Legacy player inventory may take longer to deplete than expected, delaying volume recovery.
View Risks →